Home
My Account
About Us
Forum
Contact us
الواجهة العربية
epharmaweb.com
Medical News Medical News
Aricles Articles
Events Events
Guidelines Guidelines
Videos Library Videos Library
Diseases Diseases
Follow us : facebook twitter Digg Linkedin Boxiz
Newsletter

Please select the categories you are intersted in:
News Articles Guidelines Events Videos Journals' abstracts

Latest Subscribers
Advanced Search »



Meningiomas in children and adolescents: a meta-analysis of individual patient data



Meningiomas in children and adolescents: a meta-analysis of individual patient data

Dr Rishi S Kotecha MB ChB, Elaine M Pascoe MBiostat, Prof Elisabeth J Rushing MD, Prof Lucy B Rorke-Adams MD, Prof Ted Zwerdling MD, Xing Gao MD, Xin Li MD, Stephanie Greene MD, Prof Abbas Amirjamshidi MD, Prof Seung-Ki Kim MD, Marco A Lima MD, Po-Cheng Hung MD, Fayçal Lakhdar MD, Nirav Mehta MD, Prof Yuguang Liu MD, B Indira Devi MCh, B Jayanand Sudhir MCh, Prof Morten Lund-Johansen MD, Prof Flemming Gjerris MD, Prof Catherine H Cole MBBS, Nicholas G Gottardo MB ChB

The Lancet Oncology,
12:13, November 16, 2011

Meningiomas in children and adolescents: a meta-analysis of individual patient data

Background
The epidemiological, prognostic, and therapeutic features of child and adolescent meningioma are poorly defined. Clinical knowledge has been drawn from small case series and extrapolation from adult studies. This study was done to pool and analyse the clinical evidence on child and adolescent meningioma.


Methods
Searches of PubMed, Medline, and Embase identified 35 case series of child and adolescent meningioma completed over the past 21 years. Individual patient data were obtained from 30 studies via direct communication with investigators. Primary outcomes were relapse-free survival (RFS) and overall survival. Prognostic variables were extent of initial surgery, use of upfront radiotherapy, age, sex, presence of neurofibromatosis, tumour location, and tumour grade. RFS and overall survival were analysed using Kaplan-Meier survival curves and multivariable Cox regression models.


Findings
From a total of 677 children and adolescents with meningioma, 518 were eligible for RFS analysis and 547 for overall survival analysis. Multivariable analysis showed that patients who underwent initial gross-total resection had better RFS (hazard ratio 0•16, 95% CI 0•10—0•25; p<0•0001) and overall survival (0•21, 0•11—0•39; p<0•0001) than those who had subtotal resection. No significant benefit was seen for upfront radiotherapy in terms of RFS (0•59, 0•30—1•16; p=0•128) or overall survival (1•10, 0•53—2•28; p=0•791). Patients with neurofibromatosis type 2 (NF2) had worse RFS than those without neurofibromatosis (2•36, 1•23—4•51; p=0•010). There was a significant change in overall survival with time between patients with NF2 compared with those without neurofibromatosis (1•45, 1•09—1•92; p=0•011); although overall survival was initially better for patients with NF2 than for those without neurofibromatosis, overall survival at 10 years was worse for patients with NF2. Patients with WHO grade III tumours had worse RFS than those with WHO grade I (3•90, 2•10—7•26; p<0•0001) and grade II tumours (2•49, 1•11—5•56; p=0•027).


Interpretation
Extent of initial surgical resection is the strongest independent prognostic factor for child and adolescent meningioma. No benefit for upfront radiotherapy was noted. Hence, aggressive surgical management, to achieve gross-total resection, is the initial treatment of choice. In the event of a subtotal resection, repeat resection is recommended to achieve maximum extirpation. Close observation is warranted for patients who have a subtotal resection or who have WHO grade III tumours. Patients without neurofibromatosis should have a minimum 10-year follow-up, whereas patients with NF2 should be considered a special risk category, necessitating life-long follow-up.







اضغط هنا للقراءة باللغة العربية

Prepared by: Dr. Houssam Al-Nahhas






Forgot your password


sign up

Consultants Corner

Dr. Tahsin Martini

Dr. Tahsin Martini Degree status: M.D. in Ophthalmology

Dr. Faisal Dibsi

Dr. Faisal Dibsi Specialist of Otolaryngology - Head and Neck Surgery

Yaser Habrawi , F.R.C.S.Ed

Yaser Habrawi , F.R.C.S.Ed Consultant Ophthalmologist

Samir Moussa M.D.

Samir Moussa M.D. ENT Specialist

Dr. Talal Sabouni

Dr. Talal Sabouni UROLOGY AND KIDNEY TRANSPLANT

Dr . Dirar Abboud

Dr . Dirar Abboud Hepatologist – Gastroenterologist

Dr. Samer Al-Jneidy

Dr. Samer Al-Jneidy Pediatrician

Dr. Hani Najjar

Dr. Hani Najjar Pediatrics, Neurology
Poll

Which of the following you are mostly interested in?

Cancer Research
Mental Health
Heart Disease & Diabetes
Sexual Health
Obesity and Healthy Diets
Mother & Child Health

Disclaimer : This site does not endorse or recommend any medical treatment, pharmaceuticals or brand names. More Details